pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Phase 1
    HG-CT-1
    Refractory Acute Myeloid Leukemia HemoGenyx Pharmaceuticals Plc
  • Phase 1
    HL-5101
    Solid Tumor AUM Biosciences Pte Ltd
  • Phase 2
    HLD-0915
    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Halda Therapeutics LLC
  • Phase 1
← prev
page 21 of 62
next →
Pain89
Neurology1
HLTX-001
Neuroblastoma
Hula Therapeutics Inc
  • Phase 1
    HM-16390
    Colorectal Cancer Hanmi Pharmaceuticals Co Ltd
  • Phase 2
    HMBD-002
    Dedifferentiated Liposarcoma Percheron Therapeutics Ltd
  • Phase 2
    HMPLA-251
    Solid Tumor$HCM HUTCHMED (China) Ltd
  • Phase 2
    HMPLA-580
    Solid Tumor$HCM HUTCHMED (China) Ltd
  • Preclinical
    HND-034
    Lung Cancer Handa Pharmaceuticals LLC
  • Preclinical
    HND-039
    Kidney Cancer (Renal Cell Cancer) Handa Pharmaceuticals LLC
  • Preclinical
    HND-042
    Unspecified Cancer Handa Pharmaceuticals LLC
  • Phase 1
    HNSCC
    Hypopharyngeal Cancer Metaclipse Therapeutics Corp
  • Preclinical
    HP-520
    no indication Hinova Pharmaceuticals Inc
  • Phase 2
    HPV Induced Cancers
    Cervical Cancer Theravectys SA
  • Phase 2
    HST-1011
    Anal Cancer HotSpot Therapeutics Inc
  • Preclinical
    HT-KIT
    Anaphylaxis$HOTH Hoth Therapeutics, Inc.
  • Phase 1
    HWK-007
    Endometrial Cancer$WHWK Whitehawk Therapeutics, Inc.
  • Phase 1
    HWK-016
    Endometrial Cancer$WHWK Whitehawk Therapeutics, Inc.
  • Preclinical
    HWK-206
    Neuroendocrine Tumors$WHWK Whitehawk Therapeutics, Inc.
  • Preclinical
    Half-Life Extended BiTE
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)$AMGN AMGEN INC
  • Phase 1
    Hemay-181
    Colon Cancer Ganzhou Hemei Pharmaceutical Co Ltd
  • Phase 2
    IAE-0972
    Cutaneous Squamous Cell Carcinoma (cSCC) Sunho (China) Biopharmaceutical Co Ltd
  • Phase 1
    IAM-1363
    Bladder Cancer Iambic Therapeutics Inc
  • Phase 2
    IAP-0971
    Cervical Cancer Sunho (China) Biopharmaceutical Co Ltd
  • Phase 2
    IBB-0979
    Solid Tumor Sunho (China) Biopharmaceutical Co Ltd
  • Phase 1
    IBI-3020
    Colon Cancer Innovent Biologics Inc
  • Phase 2
    IBI-363
    Metastatic Melanoma Innovent Biologics Inc
  • Preclinical
    IBIO-101
    Solid Tumor$IBIO iBio, Inc.
  • Phase 1
    IBRX-042
    Head And Neck Cancer$IBRX ImmunityBio, Inc.
  • Phase 1
    ICG-122
    T-Cell Leukemia iCell Gene Therapeutics LLC